Table 1.
No. | Reference | Age (years) |
Previous surgery |
Delay (years) |
Histology | Coexisting endometriosis on histology | Surgical treatment | CT | RT | Followup (months) |
Outcome |
---|---|---|---|---|---|---|---|---|---|---|---|
1. | Schnieber and Wagner-Kolb [8] | 40 | CS | 15 | CCC | Yes | LR, TAH + BSO | − | + | 18 | DOD |
2. | Hitti et al. [9] | 46 | CS | 14 | CCC | Yes | LR, TAH + BSO | − | − | 30 | NED |
3. | Markopoulos et al. [10] | 50 | CS | 25 | EC | No | LR | − | − | 24 | NED |
4. | Gücer et al. [11] | 45 | CS | 8 | EC | Unclear | LR | − | − | 20 | DOD |
5. | Miller et al. [12] | 38 | CS | 9 | CCC | Yes | LR, TAH + BSO | − | + | 60 | NED |
6. | Park et al. [13] | 54 | CS | 26 | CCC | Yes | LR | − | + | 6 weeks | NED |
7. | Ishida et al. [14] | 56 | CS | 24 | CCC | No | LR | − | + | 48 | DOD |
8. | Matter et al. [15] | 60 | CS | 41 | EC | Yes | LR | − | − | 18 | NED |
9. | Li et al. [16] | 38 | CS | 10 | SC | No | LR, TAH + BSO + OMT | − | − | 14 | NED |
10. | Leng et al. [17] | 41 | CS | 16 | Carcinosarcoma | Yes | LR | − | − | 15 | DOD |
11. | Sergent et al. [18] | 45 | CS | 28 | CCC | No | LR, BSO | + | − | 6 | DOD |
12. | Harry et al. [19] | 55 | CS | 30 | CCC | Yes | LR | − | + | 18 | NED |
13. | Bats et al. [20] | 38 | CS | 13 | CCC | Yes | LR, TAH + BSO | + | − | 2 | NED |
14. | Williams et al. [21] | 53 | CS | 17 | CCC | No | LR, TAH + BSO | + | + | 11 | DOD |
15. | Matsuo et al. [22] | 37 | LC | 10 | CCC | No | LR, TAH + BSO + OMT, PEN | + | − | 18 | REC |
16. | Omranipour and Najafi [23] | 59 | D & C* | 20 | SC | No | LR | + | − | 12 | NED |
17. | Bourdel et al. [24] | 43 | CS | Unclear | CCC | Unclear | LR, TAH + BSO | + | + | 22 | DOD |
18. | Shalin et al. [7] | 47 | CS | Unclear | CCC | Yes | LR | + | + | 7 | NED |
19. | Mert et al. [25] | 42 | CS, USO | Unclear | CCC | Yes | LR, TAH + BSO | + | − | 1 | NED |
20. | Mert et al. [25] | 51 | CS, TAH | Unclear | CCC | Yes | LR, BSO + OMT | − | + | 31 | NED |
21. | This case | 60 | CS | 35 | CCC | Yes | LR | − | − | 8 | REC |
BSO: bilateral salpingo-oophorectomy, CCC: clear cell adenocarcinoma, CS: cesarean section, D & C: dilatation and curettage, DOD: died of disease, EC: endometrioid adenocarcinoma, LC: laparoscopic cystectomy, LR: local resection, NED: no evidence of disease, OMT: omentectomy, PEN: pelvic lymph nodes dissection, REC: recurrence, SC: serous adenocarcinoma, TAH: total abdominal hysterectomy, USO: unilateral salpingo-oophorectomy, and *laparotomy for perforation of the uterus during D & C.